4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-097031
Director sold 212,477 shares at an average $42.93 ($9,121,902)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kersten Dirk · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-12 | Sale : show line 1 in the form 10b5-1 | −26,416 | $42.74 | $1,129,020 | 1,839,750 | I |
| 2024-08-12 | Sale : show line 2 in the form 10b5-1 | −52,076 | $43.42 | $2,261,140 | 1,787,674 | I |
| 2024-08-13 | Sale : show line 3 in the form 10b5-1 | −24,378 | $42.08 | $1,025,826 | 1,763,296 | I |
| 2024-08-13 | Sale : show line 4 in the form 10b5-1 | −88,179 | $42.78 | $3,772,298 | 1,675,117 | I |
| 2024-08-13 | Sale : show line 5 in the form 10b5-1 | −21,428 | $43.57 | $933,618 | 1,653,689 | I |
| Open-market sales · 212,477 sh · avg $42.93 · $9,121,902 | ||||||
Loading xslF345X05/ownership.xml…